INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1441343945-virus-viral-infection]( "A Simple Method For Cell Growth Media Preparation")
A Simple Method For Cell Growth Media PreparationExplore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.
-
![Emulate Liver Chip]( "A Human-Relevant Model Of The Liver Sinusoid")
A Human-Relevant Model Of The Liver SinusoidThis organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.
-
![Scalable purifications]( "Development Of Scalable Purification For Biotherapeutic Peptides")
Development Of Scalable Purification For Biotherapeutic PeptidesDiscover key strategies for reversed-phase isolation of biotherapeutic peptides, as well as learn about method development, scale-up techniques, and RP/MS analysis to enhance purification workflows.
-
![Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery Of Base Editing Tools Splash]( "Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery")
Simplify CAR-T Cell Manufacturing With LNP-Mediated DeliveryStreamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.
-
Application Of LC-UV/MS Workflows To Increase Efficiency7/29/2025
Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.
-
Biologic Stability: A Thermofluor Screen For Rational Buffer Optimization9/23/2025
Learn how thermal shift fluorimetry (thermofluor) can be used as a rapid, low-volume, and cost-effective technique to accelerate buffer optimization and enhance protein stability.
-
Improving API Solubility With Mesoporous Silica6/5/2025
Poor solubility of active pharmaceutical ingredients can hinder drug effectiveness. Learn how innovative formulation strategies enhance solubility and bioavailability to improve therapeutic outcomes for challenging drug candidates.
-
Doubling Up For Speed In Biomanufacturing12/12/2025
Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.
-
5 Trends Impacting CMOs In 20252/4/2025
In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
DRUG DEVELOPMENT SOLUTIONS
-
![HSC-Kit-Box-and-Vials_100ul_0324]( "CD34+ HSC LNP Kits")
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
![leica-microsystems-las-x-life-science-hero]( "Life Science Microscope Software Platform")
-
![leica-microsystems-dm-3000-hero]( "Uniquely Ergonomic System Microscopes With Intelligent Automation")
Leica DM3000
Enhance Laboratory Workflow
The Leica DM3000 microscopes for pathology, cytology, haematology and many other applications feature a motorized nosepiece, condenser head, automated light intensity adjustment, and optional foot pedal. These intuitive microscopes improve workflows significantly. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
![leica-microsystems-stellaris-5-cryo-hero]( "Cryo Confocal Light Microscope")
STELLARIS 5 Cryo Confocal Light Microscope
The STELLARIS 5 Cryo is a confocal light microscope system that helps you to target your area of interest for cryo-electron tomography (CryoET). The STELLARIS 5 Cryo gives you the precision to target reliably, while still offering superior performance you can count on and improved productivity for your experiments.
-
Sartorius is a leading provider of Cell Line Development Services allowing customers easy open access to a cost effective reliable technology platform. The Cellca CHO Expression Platform consistently delivers well characterized stable research clones from DNA to Research Cell Bank (RCB) in just 14 weeks with average titers of 4 g/L in an easily scalable fed batch process.
